Symbiox Investment [SYMBIOX] vs Jindal Worldwide [JINDWORLD] Detailed Stock Comparison
Symbiox Investment
BSE
Loading...
Jindal Worldwide
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Symbiox Investment wins in 11 metrics, Jindal Worldwide wins in 8 metrics, with 0 ties. Symbiox Investment appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Symbiox Investment | Jindal Worldwide | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 34.63 | 48.37 | Symbiox Investment |
| Price-to-Book Ratio | 0.27 | 4.60 | Symbiox Investment |
| Debt-to-Equity Ratio | 0.00 | 100.72 | Symbiox Investment |
| PEG Ratio | 0.04 | -8.71 | Jindal Worldwide |
| EV/EBITDA | -15.06 | 21.64 | Symbiox Investment |
| Profit Margin (TTM) | 8.70% | 3.22% | Symbiox Investment |
| Operating Margin (TTM) | 19.32% | 7.02% | Symbiox Investment |
| EBITDA Margin (TTM) | 19.32% | 7.02% | Symbiox Investment |
| Return on Equity | 0.60% | 9.60% | Jindal Worldwide |
| Return on Assets (TTM) | 0.60% | 4.22% | Jindal Worldwide |
| Free Cash Flow (TTM) | $35.83M | $1.45B | Jindal Worldwide |
| Dividend Yield | N/A | 1.20% | N/A |
| 1-Year Return | -36.18% | -47.47% | Symbiox Investment |
| Price-to-Sales Ratio (TTM) | 2.98 | 1.56 | Jindal Worldwide |
| Enterprise Value | $-51.07M | $42.53B | Jindal Worldwide |
| EV/Revenue Ratio | -1.76 | 1.82 | Symbiox Investment |
| Gross Profit Margin (TTM) | 49.18% | 24.12% | Symbiox Investment |
| Revenue per Share (TTM) | $1 | $23 | Jindal Worldwide |
| Earnings per Share (Diluted) | $0.08 | $0.75 | Jindal Worldwide |
| Beta (Stock Volatility) | -1.22 | -0.53 | Symbiox Investment |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Symbiox Investment vs Jindal Worldwide Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Symbiox Investment | 0.36% | 2.97% | -2.12% | -4.81% | -17.56% | -47.34% |
| Jindal Worldwide | -1.70% | -8.41% | 2.72% | -35.41% | -34.98% | -57.54% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Symbiox Investment | -36.18% | -63.70% | 201.09% | -79.88% | -79.88% | -79.88% |
| Jindal Worldwide | -47.47% | -33.17% | 281.83% | 992.10% | 593.63% | 593.63% |
News Based Sentiment: Symbiox Investment vs Jindal Worldwide
Symbiox Investment
News based Sentiment: NEUTRAL
The month's events primarily consist of routine corporate governance activities – a board meeting, an AGM announcement, and a regulatory filing. While important for maintaining a healthy company structure, these events don't represent significant shifts in strategy or performance, resulting in a neutral overall sentiment.
Jindal Worldwide
News based Sentiment: NEGATIVE
September brought disappointing financial results and a 'Strong Sell' recommendation for Jindal Worldwide, overshadowing minor positive developments like Shariah compliance and board changes. The company's continued underperformance and declining share price signal significant risks for investors, making this a crucial month to reassess investment strategies.
Performance & Financial Health Analysis: Symbiox Investment vs Jindal Worldwide
| Metric | SYMBIOX | JINDWORLD |
|---|---|---|
| Market Information | ||
| Market Cap | ₹86.67M | ₹37.11B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 55,368 | 1,375,715 |
| 90 Day Avg. Volume | 57,405 | 3,697,552 |
| Last Close | ₹2.78 | ₹35.32 |
| 52 Week Range | ₹2.33 - ₹6.02 | ₹33.89 - ₹94.24 |
| % from 52W High | -53.82% | -62.52% |
| All-Time High | ₹26.20 (Feb 01, 2016) | ₹95.34 (Jan 02, 2023) |
| % from All-Time High | -89.39% | -62.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.47% | 0.10% |
| Quarterly Earnings Growth | 10.95% | -0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.03% |
| Operating Margin (TTM) | 0.19% | 0.07% |
| Return on Equity (TTM) | 0.01% | 0.10% |
| Debt to Equity (MRQ) | 0.00 | 100.72 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹10.14 | ₹7.89 |
| Cash per Share (MRQ) | ₹4.40 | ₹2.98 |
| Operating Cash Flow (TTM) | ₹36.19M | ₹817.35M |
| Levered Free Cash Flow (TTM) | ₹1.92M | ₹758.69M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.20% |
| Last 12-Month Dividend | N/A | ₹0.69 |
Valuation & Enterprise Metrics Analysis: Symbiox Investment vs Jindal Worldwide
| Metric | SYMBIOX | JINDWORLD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 34.63 | 48.37 |
| Forward P/E | N/A | N/A |
| PEG Ratio | 0.04 | -8.71 |
| Price to Sales (TTM) | 2.98 | 1.56 |
| Price to Book (MRQ) | 0.27 | 4.60 |
| Market Capitalization | ||
| Market Capitalization | ₹86.67M | ₹37.11B |
| Enterprise Value | ₹-51,065,096 | ₹42.53B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | -1.76 | 1.82 |
| Enterprise to EBITDA | -15.06 | 21.64 |
| Risk & Other Metrics | ||
| Beta | -1.22 | -0.53 |
| Book Value per Share (MRQ) | ₹10.14 | ₹7.89 |
Financial Statements Comparison: Symbiox Investment vs Jindal Worldwide
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SYMBIOX | JINDWORLD |
|---|---|---|
| Revenue/Sales | ₹4.58M | ₹5.40B |
| Cost of Goods Sold | ₹2.33M | ₹4.10B |
| Gross Profit | ₹2.25M | ₹1.30B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹885,000 | ₹351.92M |
| EBITDA | ₹911,000 | ₹430.31M |
| Pre-Tax Income | ₹904,000 | ₹227.56M |
| Income Tax | ₹235,000 | ₹53.18M |
| Net Income (Profit) | ₹669,000 | ₹174.39M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SYMBIOX | JINDWORLD |
|---|---|---|
| Cash & Equivalents | ₹10.59M | ₹275.33M |
| Total Current Assets | ₹319.51M | ₹14.05B |
| Total Current Liabilities | ₹2.42M | ₹8.36B |
| Long-Term Debt | ₹0 | ₹1.59B |
| Total Shareholders Equity | ₹317.24M | ₹7.90B |
| Retained Earnings | ₹3.93M | ₹6.88B |
| Property, Plant & Equipment | ₹151,563 | ₹84.76M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SYMBIOX | JINDWORLD |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SYMBIOX | JINDWORLD |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 55,368 | 1,375,715 |
| Average Daily Volume (90 Day) | 57,405 | 3,697,552 |
| Shares Outstanding | 31.29M | 1.00B |
| Float Shares | 24.61M | 85.13M |
| % Held by Insiders | 0.18% | 0.92% |
| % Held by Institutions | 0.00% | 0.00% |
Dividend Analysis & Yield Comparison: Symbiox Investment vs Jindal Worldwide
| Metric | SYMBIOX | JINDWORLD |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.69 |
| Last 12-Month Dividend Yield | N/A | 1.20% |
| 3-Year Avg Annual Dividend | N/A | ₹0.23 |
| 3-Year Avg Dividend Yield | N/A | 0.33% |
| 3-Year Total Dividends | N/A | ₹0.70 |
| Ex-Dividend Date | N/A | Sep 09, 2024 |